Class Denied In Paxil Case

Law360, New York (January 26, 2007, 12:00 AM EST) -- Plaintiffs alleging that GlaxoSmithKline PLC knew about risks related to adolescents’ use of antidepressant Paxil, but failed to warn doctors and the public, were denied class certification Thursday.

The ruling in the U.S. District Court in the Eastern District of Pennsylvania denied the certification of a national class. The plaintiffs sought to represent “all persons whose children under the age eighteen committed or attempted to commit suicide while using the drug,” the decision said.

In denying class certification, Judge Timothy J. Savage said that class action...
To view the full article, register now.